CBT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cabot Corp (CBT) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The lack of positive catalysts, weak financial performance, and neutral trading sentiment suggest that holding off on buying is prudent at this time.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 39.23, and while the moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the stock is trading near key support at 73.15. Overall, the technical indicators do not strongly support a buy.
NULL identified. No recent news or significant insider/hedge fund activity to drive the stock higher.
Weak financial performance in Q1 2026, with revenue down 11.10% YoY, net income down 21.74% YoY, and EPS down 18.56% YoY. Analysts have downgraded the stock due to weak demand for key products and lack of recovery in sight.
In Q1 2026, revenue dropped to $849M (-11.10% YoY), net income decreased to $72M (-21.74% YoY), and EPS fell to 1.36 (-18.56% YoY). Gross margin increased slightly to 24.85% (+0.98% YoY), but overall financials indicate a declining growth trend.
Deutsche Bank raised the price target to $80 but maintained a Hold rating. UBS raised the price target to $81 with a Neutral rating. Mizuho downgraded the stock to Neutral from Outperform, citing weak demand and a lack of recovery. The overall sentiment is neutral to slightly negative.
